TNFA: TNF Pharmaceuticals, Inc. Stock

by  •  • Comments Off on TNFA: TNF Pharmaceuticals, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 1.98
Enterprise Value ($M) 1.21
Book Value ($M) 17.06
Book Value / Share 6.19
Price / Book 0.12
NCAV ($M) 5.04
NCAV / Share 1.83
Price / NCAV 0.39

Profitability (mra)
Return on Invested Capital (ROIC) -1.39
Return on Assets (ROA) -1.32
Return on Equity (ROE) -1.85

Liquidity (mrq)
Quick Ratio 1.72
Current Ratio 1.72

Balance Sheet (mrq) ($M)
Current Assets 12.03
Assets 24.04
Liabilities 6.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Global X Management CO LLC 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 59,907 197,565 30.32
2025-02-03 114,987 360,554 31.89
2025-01-31 35,576 156,854 22.68
2025-01-30 129,256 417,512 30.96

(click for more detail)

Similar Companies
THTX – Theratechnologies Inc. TIL – Instil Bio, Inc.
TLSA – Tiziana Life Sciences Ltd TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io